Medical Scientist Training Program (MSTP)

Medical Scientist Training Program

Featured Student

uploadedImages/education/mstp/featured-students/louisa-steinberg.jpg

Louisa Steinberg

The first year in the MSTP at the Einstein is great! My classmates and I have lunch with the program director every week. Free food, accessiblity to the director, and a chance to give feedback about the MSTP. What more could a student ask for? A studio apartment and a stipend, you say? Yeah, we get that too.

 

The Medical Scientist Training Program (MSTP) at the Albert Einstein College of Medicine (Einstein) is one of the nation’s oldest. From the start, our goal has been to train a diverse group of outstanding students to become future leaders of academic medicine and medical research. Continuously funded by the National Institutes of Health since 1964, the Einstein MSTP has 473 illustrious Alumni with careers spanning the spectrum from basic science research to clinical medicine and many variations in between.

Today, the Einstein MSTP is still unique. Larger than most other MSTPs, it fosters a strong academic and social community within the college. While large enough to be an independent academic unit, the program is still small enough to provide students with the individual attention their unique careers require.

The current training program recognizes that the successful physician-scientist training is not simply medical school plus graduate training. The program integrates MSTP-specific courses with medical and graduate courses, during the first two years of preclinical course work. Integration continues in the PhD thesis years through weekly involvement in the MSTP Continuity Clinic and monthly Clinical Pathological Conferences and MSTP Career Paths seminars.

Students have outstanding publications and residency placements.

Because of the COVID pandemic our interview process for the class entering in 2021 will be entirely virtual. To learn more about the Einstein community please view these two short videos: Life at Einstein and The Class of 2024. 

The Einstein MSTP encourages applications from all individuals. As stated in the College's Diversity and Inclusion Strategic Plan for Excellence, "At Einstein, we value all people and perspectives that make us unique and increase our diversity at large. Albert Einstein College of Medicine reaffirms its commitment to recruiting, retaining and advancing individuals from historically underrepresented and marginalized minority groups in the scientific and medical professions. At the College of Medicine, this includes, (in no particular order, and is not limited to) women, individuals who are Black, Latino/Latina; Pacific Islander or indigenous Americans; individuals from new immigrant populations; individuals with both apparent and nonapparent disabilities; all sexual and gender minorities, including lesbian, gay, bisexual, asexual and queer people as well as transgender, gender-nonconforming and intersex individuals; religious minorities and individuals from economically disadvantaged backgrounds."

Four M.D./Ph.D. students share what motivates them to pursue the long and rigorous course to become physician-scientists.  

Awards & Accomplishments

  • Henrietta Bains NIH NRSA F31 Fellowship for a project entitled "How does mTOR sense lipid in vivo" (Sponsor,  Rajat Singh, Developmental & Molecular Biology)
  • Julio Flores NIH NRSA F31 Fellowship for a project entitled "Epigenetic regulation of stem cells and development by the DNA dioxygenase Te2" (Sponsor,  Meelad Dawlaty, Genetics)
  • Daniel Borger NIH NRSA F30 Fellowship for a project entitled "Developing a novel ex vivo platform to support hematopoietic cells and characterize the stem cell niche" (Sponsor,  Paul Frenette, Cell Biology)
  • Ryan Malonis NIH NRSA F30 Fellowship for a project entitled "Discovery & characterization of human monoclonal antibodies targeting multiple arthritogenic alphaviruses" (Sponsor, Jon Lai, Biochemistry)
  • Bianca Ulloa NIH NRSA F31 Fellowship for a project entitled "Deciphering the development of hematopoietic stem and progenitor cell self-renewal and differentiation" (Sponsor,  Teresa Bowman, Developmental & Molecular Biology)
  • Taylor Thompson NIH NRSA F31 Fellowship for a project entitled "Transcriptional Regulatory and Cell Differentiation Influences of an Endocrine Disrupting Chemical" (Sponsor, John Greally, Genetics)
  • Michelle Gulfo NIH NRSA F31 Fellowship for a project entitled "Assessing dopaminergic modulation of an associative circuit within the dentate gyrus" (Sponsor, Pablo Castillo, Neuroscience)
  • Meera Trivedi NIH NRSA F31 Fellowship for a project entitled "Characterizing Novel Regulations of Dendritic Tiling in C. elegans" (Sponsor, Hannes Buelow, Neuroscience)
  • Jamie Moore NIH NRSA F31 Fellowship for a project entitled "Unraveling Mechanisms of Plasmacytoid Dendritic Cell Priming by CD169+ Macrophages in Severe Murine Malaria" (Sponsor, Gregoire Lauvau, Microbiology & Immunology)
  • Adam Spitz NIH NRSA F30 Fellowship for a project entitled "Direct Small Molecule Activation of Pro-apoptotic BAK" (Sponsor, Evris Gavathiotis, Biochemistry)
  • Hayden Hatch NIH NRSA F31 Fellowship for a project entitled "Transcriptional regulation, neuronal development, and function of the mushroom body in a Drosophila model of intellectual disability" (Co-Sponsors, Julie Secombe and Nicholas Baker, Neuroscience/Genetics)
  • Joshua Weinreb NIH NRSA F30 Fellowship for a project entitled "Uncovering the Role of the DEAD Box Helicase Ddx41 in Hematopoiesis" (Sponsor, Teresa Bowman, Developmental & Molecular Biology)
  • Rosiris Leon-Rivera NIH NRSA F31 Fellowship for a project entitled "Molecular Mechanisms of Increased Risk of Racial and Ethnic Minorities for HIV Associated Neurocognitive Disorders" (Sponsor, Joan Berman, Pathology)
  • Todd Rubin NIH NRSA F31 Fellowship for a project entitled "Examining sex as a predictor of outcomes across multiple levels of head trauma" (Sponsor, Michael Lipton, Neuroscience)
  • Niloy Iqbal NIH NRSA F30 Fellowship for a project entitled "Tumor Suppressor pRb is a Novel Target for Hypothalamic Inhibition of Diet Induced Obesity" (Sponsors, Liang Zhu and Streamson Chua, Jr., Developmental & Molecular Biology)
  • Kristin Palarz NIH NRSA F31 Fellowship for a project entitled "Serotoninergic modulation of cerebellar circuitry" (Sponsor, Kamran Khodakhah, Neuroscience)
  • Peter John NIH NRSA F30 Fellowship for a project entitled "B7x in Cancer: Mechanisms and Therapies" (Sponsor, XingXing Zang, Microbiology & Immunology)
  • Richard Piszczatowski NIH NRSA F30 Fellowship for a project entitled "Investigating the role of Nol3 in normal and malignant hematopoiesis" (Sponsor, Ulrich Steidl, Cell Biology)
  • Jeet Biswas NIH NRSA F30 Fellowship for a project entitled "The sequence recognition, structure and function of the IMP family of mRNA binding proteins" (Sponsor, Robert Singer, Anatomy & Structural Biology)
  • Sean Healton NIH NRSA F30 Fellowship for a project entitled "Epigenetic activity of normal and cancer-associated mutant H1 linker histones" (Sponsor, Arthur Skolutchi, Cell Biology)

 more awards 

Publications

  • publications Weinreb JT, Gupta V, Sharvit E, Weil R, Bowman TV. Ddx41 inhibition of DNA damage signaling permits erythroid progenitor expansion in zebrafish. Haematologica. 2021 Mar 25
  • publications Hatch HA, Belalcazar HM, Marshall OJ, Secombe J. A KDM5-Prospero transcriptional axis functions during early neurodevelopment to regulate mushroom body formation. Elife. 2021 Mar 17
  • publications León-Rivera R, Veenstra M, Donoso M, Tell E, Eugenin EA, Morgello S, Berman JW. Central Nervous System (CNS) Viral Seeding by Mature Monocytes and Potential Therapies To Reduce CNS Viral Reservoirs in the cART Era. mBio. 2021 Mar 16
  • publications Sweeney JM, Barouqa M, Krause GJ, Gonzalez-Lugo JD, Rahman S, Gil MR. Low ADAMTS13 Activity Correlates with Increased Mortality in COVID-19 Patients. TH Open. 2021 Mar 9
  • publications Ueda K, Kumari R, Schwenger E, Wheat JC, Bohorquez O, Narayanagari SR, Taylor SJ, Carvajal LA, Pradhan K, Bartholdy B, Todorova TI, Goto H, Sun D, Chen J, Shan J, Song Y, Montagna C, Xiong S, Lozano G, Pellagatti A, Boultwood J, Verma A, Steidl U. MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism. Cancer Cell. 2021 Mar
  • publications Weinreb JT, Ghazale N, Pradhan K, Gupta V, Potts KS, Tricomi B, Daniels NJ, Padgett RA, De Oliveira S, Verma A, Bowman TV. Excessive R-loops trigger an inflammatory cascade leading to increased HSPC production. Dev Cell. 2021 Feb 23
  • publications MacArthur IC, Dawlaty MM. TET Enzymes and 5-Hydroxymethylcytosine in Neural Progenitor Cell Biology and Neurodevelopment. Front Cell Dev Biol. 2021 Feb 18
  • publications Spitz AZ, Zacharioudakis E, Reyna DE, Garner TP, Gavathiotis E. Eltrombopag directly inhibits BAX and prevents cell death. Nat Commun. 2021 Feb 18
  • publications Fels JM, Bortz RH 3rd, Alkutkar T, Mittler E, Jangra RK, Spence JS, Chandran K. A Glycoprotein Mutation That Emerged during the 2013-2016 Ebola Virus Epidemic Alters Proteolysis and Accelerates Membrane Fusion. mBio. 2021 Feb 16

more publications 

Click here to log in
Medical Scientist Training Program (MSTP)